VIRTUAL Reviewing CMC Considerations for Manufacturing Gene Modified T-Cell Products

Time: 4:00 pm
day: Day Two


• Highlighting some of the major challenges associated with developing gene modified T-cell products
• Discussing phase appropriate CMC considerations for CAR/TCR-T cell product development
• Exploring best practices to manage CMC related challenges during T-cell product development